Trends in tumors in the central nervous system in elderly in Denmark, 2008-2012

Acta Oncologica
Rikke H DahlrotAcademy of Geriatric Cancer Research (AgeCare)

Abstract

Tumors in the central nervous system (CNS) comprise a heterogeneous group of tumors with different treatment strategies and prognoses. Current treatment regimens are based on studies on patients mainly younger than 70 years. The aim of the present study was to analyze and describe trends in incidence, mortality, prevalence, and relative survival in Denmark from 1980 to 2012 focusing on patients older than 70 years. Tumors in the CNS were defined as ICD-10 codes C70-72, D32-33 and D42-43. Data with comparable data on cancer incidence, mortality, prevalence and relative survival derived from the NORDCAN database were delivered from the Danish Cancer Registry and the Danish Cause of Death Registry with follow-up for death or emigration until the end of 2013. During the period 1980-2012 the number of patients with CNS tumors increased from 603 to 1378 patients. The increase is seen mainly in the elderly patients, and especially in women aged 84-89 and 90 + at the time of diagnosis. During the same time period, the mortality rates increased within all age groups, most significantly in patients aged 70 years or older. This may reflect an increased focus on and identification of these patients. Noteworthy; the number of patients livin...Continue Reading

References

Dec 26, 2003·Statistics in Medicine·Paul W DickmanTimo Hakulinen
Mar 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W RoaP Forsyth
Mar 11, 2005·The New England Journal of Medicine·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Apr 13, 2007·The New England Journal of Medicine·Florence Keime-GuibertUNKNOWN Association of French-Speaking Neuro-Oncologists
Jul 10, 2007·Acta Neuropathologica·David N LouisPaul Kleihues
Apr 22, 2008·Neurosurgery·Walter StummerUNKNOWN ALA-Glioma Study Group
Sep 21, 2010·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Johanna GersteinClaus Rödel
May 15, 2012·The Lancet Oncology·Wolfgang WickUNKNOWN NOA-08 Study Group of Neuro-oncology Working Group (NOA) of German Cancer Society
Oct 17, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Martin J van den BentKhê Hoang-Xuan
Apr 19, 2013·Neuro-oncology·Benedikt WiestlerUNKNOWN Neuro-oncology Working Group (NOA) of the German Cancer Society
May 10, 2013·International Journal of Epidemiology·Victoria S BensonUNKNOWN Million Women Study Collaborators
Jul 30, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Grace L Smith, Benjamin D Smith
Aug 1, 2014·The Lancet Oncology·Michael WellerUNKNOWN European Association for Neuro-Oncology (EANO) Task Force on Malignant Glioma
Jan 20, 2016·Acta Oncologica·Marianne EwertzUNKNOWN Academy of Geriatric Cancer Research (AgeCare)

❮ Previous
Next ❯

Citations

Feb 6, 2019·Proceedings of the National Academy of Sciences of the United States of America·Sara Diamond
Sep 5, 2018·Frontiers in Medicine·Khalaf Kridin, Ralf J Ludwig

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Acta Oncologica
Jeanette D JensenAcademy of Geriatric Cancer Research (AgeCare)
Acta Oncologica
Charlotte KristiansenAcademy of Geriatric Cancer Research (AgeCare)
Acta Oncologica
Stine Brændegaard WintherAcademy of Geriatric Cancer Research (AgeCare)
Acta Oncologica
Katrine R SchønnemannAcademy of Geriatric Cancer Research (AgeCare)
Acta Oncologica
Jon Kroll BjerregaardAcademy of Geriatric Cancer Research (AgeCare)
© 2022 Meta ULC. All rights reserved